Company

Osprey Pharmaceuticals USA

Osprey Pharmaceuticals USA acquires and sells premium domain names.

About

Osprey Pharmaceuticals USA acquires and sells premium domain names to businesses and entrepreneurs. Based in San Francisco, US, it raised USD 6.20 mn in a Series A round in May 2009 from investors including BDC Capital and Novo Nordisk A/S. The company is at the Series A stage.

4Funding rounds

7Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in